Antisedan is a drug owned by ORION CORP. It is protected by 2 US drug patents filed from 2007 to 2010. All patents have expired. Details of Antisedan’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US4933359 | 14 May, 2007 | Expired |
Exclusivity Information
Antisedan holds 1 exclusivity out of which 1 has expired. Details of Antisedan's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Dec 01, 2009 |
About Antisedan
Antisedan is a drug
owned by ORION CORP.
Antisedan uses
Atipamezole Hydrochloride as the active
ingredient.
Active Ingredient:
Antisedan uses
Atipamezole Hydrochloride as the active ingredient.
Check out other Drugs and Companies using
Atipamezole Hydrochloride ingredient.